Acura Pharma (ACUR) Reports Q4 Loss of $0.06

March 2, 2015 4:20 PM EST

Acura Pharma (NASDAQ: ACUR) reported Q4 EPS of ($0.06), versus ($0.07) reported last year.

For earnings history and earnings-related data on Acura Pharma (ACUR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings